| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |